Torfgård K[au] - Search Results

Year	Number of Results
1989	2
1990	2
1991	2
1992	3
1993	2
1994	1
1995	1
2020	1
2021	1
2024	0

1

Torfgård KE, Ahlner J. Torfgård KE, et al. Cardiovasc Drugs Ther. 1994 Oct;8(5):701-17. doi: 10.1007/BF00877117. Cardiovasc Drugs Ther. 1994. PMID: 7873467 Review.

2

Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.

Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN. Baumann U, et al. Among authors: torfgard k. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101751. doi: 10.1016/j.clinre.2021.101751. Epub 2021 Jun 26. Clin Res Hepatol Gastroenterol. 2021. PMID: 34182185 Clinical Trial.

3

Organic nitrate esters: clinical use and mechanisms of actions.

Ahlner J, Andersson RG, Torfgård K, Axelsson KL. Ahlner J, et al. Among authors: torfgard k. Pharmacol Rev. 1991 Sep;43(3):351-423. Pharmacol Rev. 1991. PMID: 1956955 Review. No abstract available.

4

Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.

Verkade HJ, Thompson RJ, Arnell H, Fischler B, Gillberg PG, Mattsson JP, Torfgård K, Lindström E. Verkade HJ, et al. Among authors: torfgard k. J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):176-183. doi: 10.1097/MPG.0000000000002789. J Pediatr Gastroenterol Nutr. 2020. PMID: 32433433

5

Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect of tolerance development.

Torfgård K, Ahlner J, Axelsson KL, Norlander B, Bertler A. Torfgård K, et al. Can J Physiol Pharmacol. 1991 Sep;69(9):1257-61. doi: 10.1139/y91-184. Can J Physiol Pharmacol. 1991. PMID: 1661636

6

Tissue distribution of glyceryl trinitrate and the effect on cGMP levels in rat.

Torfgård K, Ahlner J, Axelsson KL, Norlander B, Bertler A. Torfgård K, et al. Pharmacol Toxicol. 1989 Apr;64(4):369-72. doi: 10.1111/j.1600-0773.1989.tb00667.x. Pharmacol Toxicol. 1989. PMID: 2546144

7

Relaxation of bovine mesenteric arteries by glyceryl trinitrate and other nitro-compounds: evidence for partly different mechanisms of action.

Torfgård K, Ahlner J, Axelsson KL. Torfgård K, et al. Pharmacol Toxicol. 1990 Sep;67(3):216-21. doi: 10.1111/j.1600-0773.1990.tb00816.x. Pharmacol Toxicol. 1990. PMID: 2123985

8

Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.

Torfgård KE, Ahlner J, Axelsson KL, Norlander B, Bertler A. Torfgård KE, et al. Drug Metab Dispos. 1992 Jul-Aug;20(4):553-8. Drug Metab Dispos. 1992. PMID: 1356734

9

[Impermeable equipment should be used for intravenous infusions of nitroglycerin].

Norlander B, Torfgård K, Ahlner J. Norlander B, et al. Among authors: torfgard k. Lakartidningen. 1992 Feb 5;89(6):376, 379. Lakartidningen. 1992. PMID: 1738264 Swedish. No abstract available.

10

Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.

Torfgård KE, Svedjeholm R, Håkansson E, Ahlner J. Torfgård KE, et al. Arzneimittelforschung. 1995 Sep;45(9):963-6. Arzneimittelforschung. 1995. PMID: 7488313 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year